StockData
Opus Genetics, Inc. logo

Opus Genetics, Inc. (IRD) stock

IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$4.05+0.01 (+0.25%)

Close on Nov 17, 2026Market cap $336.94MP/E –Yield –

Opus Genetics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Opus Genetics's market cap was $356.21M on Nov 11, 2026, against $137.48M a year earlier. Over the last 5 years it ranged from $29.08M to $400.02M, with a median of $64.45M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$356.21M+174.6%
2025Dec 31, 2025$129.73M+316.1%
2024Dec 31, 2024$31.18M-54.2%
2023Dec 29, 2023$68.06M-7.3%
2022Dec 30, 2022$73.43M+13.8%
2021Dec 31, 2021$64.51M+121.7%
2020Dec 31, 2020$29.10M-5.2%
2019Dec 31, 2019$30.71M-74.0%
2018Dec 31, 2018$118.12M-48.6%
2017Dec 29, 2017$229.96M+73.0%
2016Dec 30, 2016$132.93M-48.9%
2015Dec 31, 2015$260.28M-47.9%
2014Dec 31, 2014$499.11M+82.0%
2013Dec 31, 2013$274.26M+132.0%
2012Dec 31, 2012$118.23M-18.4%
2011Dec 30, 2011$144.80M–

More Opus Genetics figures

See a number that looks wrong?